Community and Healthcare-Associated Infections Reduction Act of 2007
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S13630-13632)
Congressional Research Service
Official summary
Version 00 · Introduced in Senate · Oct 31, 2007
Community and Healthcare-Associated Infections Reduction Act of 2007 - Directs the Agency for Healthcare Research and Quality (AHRQ), in collaboration with the Centers for Disease Control and Prevention (CDC), to develop best-practices guidelines for internal infection control plans to prevent, detect, control, and treat community and healthcare-associated infections at hospitals.
Requires AHRQ to: (1) establish best practices with supporting justification, including the establishment of an infection control oversight committee; (2) collaborate with other agencies and organizations whose area of expertise is the identification, treatment, and prevention of infectious disease; (3) publish proposed guidelines; (4) provide for a comment period of not less than 90 days; and (5) establish final guidelines.
Directs the Administrator of the Centers for Medicare and Medicaid Services to: (1) consult best practices guidelines in evaluating hospitals' infection control plans as a condition of participation in the Medicare program; and (2) report to Congress on the feasibility of reducing healthcare-associated infection rates through a Quality Improvement Payment Program.
Showing the opening paragraphs of the official summary.
Read full official summaryShow less
Requires: (1) hospitals to report information about community and healthcare-associated infections to the CDC National Healthcare Safety Network, which shall be used by the CDC to develop a national database of infection rates in hospitals; (2) the Director of the CDC to award grants to states to carry out public awareness campaigns; (3) the Director of the National Institutes of Health (NIH) to expand and intensify NIH programs regarding research and related activities concerning such infections; (4) the Secretary of Health and Human Services to establish an interagency working group on community and healthcare-associated infections; and (5) the Government Accountability Office (GAO) to report to Congress on this Act's impact.
Source last updated: Aug 14, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Explore the bill from different angles
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Neutral evidence review
Objective
Analyze S.2278 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
View full prompt & sources
Fairness and public impact
Progressive lens
Examine S.2278 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
View full prompt & sources
Institutions and government scope
Conservative lens
Examine S.2278 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
View full prompt & sources
Individual rights and government power
Liberty lens
Examine S.2278 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.